Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
Koselugo (selumetinib) - AstraZeneca
http://clinicaltrials.gov/ct2/show/NCT05253131
Dec 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next